Obesity promoting protein malonylation and chondrocyte metabolic dysfunction in osteoarthritis development
肥胖促进骨关节炎发展中的蛋白质丙二酰化和软骨细胞代谢功能障碍
基本信息
- 批准号:10424671
- 负责人:
- 金额:$ 45.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-01 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:ADAMTSAcetylationAdultAffectAgeAge-YearsAgingAreaBindingBiological AssayBiomedical ResearchBloodBone SpurCarbonCartilageCellsChondrocytesCollagen Type IIContralateralDataDegenerative polyarthritisDevelopmentDiseaseElderlyEnzyme-Linked Immunosorbent AssayEnzymesEpitopesFutureGenesGenetic ModelsGenus HippocampusGoalsHandHeadHigh Fat DietHumanImpairmentIn VitroIncidenceIndividualInflammationInflammatoryInterleukin-1 betaJointsKnee OsteoarthritisKnowledgeLeadLinkLiteratureLongevityMass FragmentographyMatrix MetalloproteinasesMeasuresMediatingMetabolicMetabolic ControlMetabolic dysfunctionMetabolismMethodsMissionMusObese MiceObesityObesity EpidemicOhioOvernutritionOxygen ConsumptionPathologyPharmaceutical PreparationsPhenotypePlayPost-Translational Protein ProcessingPrevalenceProcessProteinsPublic HealthRegulator GenesRegulatory PathwayReportingResearchReverse Transcriptase Polymerase Chain ReactionRiskRisk FactorsRoleSerumSignal PathwaySirtuinsStressStudentsSynovitisTestingTherapeuticTissuesTrainingUnited States National Institutes of HealthUniversitiesWorkadverse outcomeaggrecanbasecartilage degradationcostdiet-induced obesitydisabilityeffective interventiongene synthesisgraduate studentin vivojoint destructionjoint loadingmechanical loadmouse geneticsmouse modelnew therapeutic targetnovelobesity biomarkerspreventprogramspublic health relevancestudent mentoringtheoriestissue procollagenaseundergraduate student
项目摘要
Project Summary/Abstract
Most older adults (~70 years of age) have some signs of osteoarthritis (OA) in their joints. Development of OA
can also be accelerated by ~20 years in individuals who are obese. This phenomenon does not stem solely from
greater mechanical loading, obesity also increases OA risk in non-weight-bearing hand joints. Obesity can
produce adverse outcomes in part because it alters metabolism at both a whole-body level and a cellular level.
However, it is unknown how joint cells change metabolism during aging and obesity. Identifying metabolic
changes in joint cells during aging and obesity could inform effective interventions and therapeutic strategies
that reduce the incidence and impact of OA, especially in the context of an increasing prevalence of obesity and
extended lifespans. This project will investigate a new theory of cell metabolic damage called "carbon stress",
which describes how over-nutrition causes metabolic byproducts to accumulate in cells, bind to metabolic
proteins, and decrease protein activity. We hypothesize that obesity-associated ‘carbon stress’ also occurs in
cartilage (chondrocytes) and plays an important role in OA development. Our previous work shows that one type
of carbon stress associated with protein post-translational malonylation (MaK) is highly elevated in cartilage
during obesity. We also showed that Sirt5, an enzyme that can remove MaK, declines during aging, suggesting
that cellular defenses against carbon stress are compromised during aging. Yet how do MaK and its regulatory
pathways contribute to cellular metabolism in chondrocytes? Guided by our preliminary data and the literature,
we will investigate this question via two specific aims: Aim 1. To test the hypothesis that obesity promotes MaK
to accelerate OA development; Aim 2. To determine the mechanisms by which Sirt5-MaK regulates cartilage
degeneration under obesity associated pro-inflammatory condition. Well-established mouse models of diet-
induced obesity and OA will be used in combination with genetically modified mouse models that allow
conditional deletion of MaK regulatory genes in cartilage. Mouse OA phenotyping will be used to examine the
consequences of enhancing or inhibiting MaK on OA pathology. In vivo and in vitro metabolic profiling methods
will be leveraged to determine the effects of manipulating MaK on chondrocyte cellular metabolism. Successful
completion of this research is expected to provide more comprehensive understanding of how obesity and aging
damage metabolism in joint cells and promote OA development, offering the potential to provide new therapeutic
targets for OA treatment. The proposed project will also serve as a perfect vehicle for the PI to continue the on-
going endeavor of mentoring students and engaging students in biomedical research.
项目摘要/摘要
大多数老年人(约70岁)的关节有一些骨关节炎(OA)的迹象。办公自动化的发展
对于肥胖的人来说,也可以加速大约20年。这种现象不仅仅源于
更大的机械负荷,肥胖也会增加非负重手关节的骨性关节炎风险。肥胖可以
产生不良后果的部分原因是它改变了全身和细胞水平的新陈代谢。
然而,关节细胞在衰老和肥胖过程中如何改变新陈代谢尚不清楚。确定代谢
衰老和肥胖过程中关节细胞的变化可以为有效的干预和治疗策略提供依据
减少骨质疏松症的发生率和影响,特别是在肥胖率和
延长寿命。该项目将研究一种新的细胞代谢损伤理论,称为“碳应激”,
它描述了过度营养如何导致代谢副产物在细胞内积累,与代谢结合
蛋白质,并降低蛋白质活性。我们假设肥胖相关的“碳压力”也发生在
软骨(软骨细胞)在骨性关节炎的发生发展中起着重要作用。我们之前的工作表明,有一种类型
翻译后丙二酸化蛋白(MAK)相关的碳应激在软骨中高度升高
在肥胖期间。我们还发现,SIRT5,一种可以清除MAK的酶,在衰老过程中会下降,这表明
细胞对碳压力的防御在衰老过程中受到损害。然而,Mak及其监管机构是如何
软骨细胞的代谢途径对细胞代谢有贡献吗?根据我们的初步数据和文献,
我们将通过两个具体的目标来研究这个问题:目标1.检验肥胖促进Mak的假设
促进骨性关节炎的发生;目的2.确定SIRT5-Mak调节软骨的机制
肥胖相关的促炎状态下的变性。成熟的小鼠饮食模型-
诱导性肥胖和骨性关节炎将与转基因小鼠模型结合使用,
软骨中Mak调控基因的条件性缺失。将使用小鼠的OA表型来检查
增强或抑制MAK对骨关节炎病理的影响。体内和体外代谢谱方法
将被用来确定操纵MAK对软骨细胞细胞代谢的影响。成功
这项研究的完成有望更全面地了解肥胖和衰老是如何
破坏关节细胞的代谢,促进骨性关节炎的发展,为提供新的治疗方法提供了潜力
骨性关节炎治疗的靶点。拟议的项目也将成为私募股权投资公司继续开展-
努力辅导学生,让学生参与生物医学研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shouan Zhu其他文献
Shouan Zhu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shouan Zhu', 18)}}的其他基金
Growth hormone regulating chondrocyte metabolism for osteoarthritis development
生长激素调节软骨细胞代谢促进骨关节炎的发展
- 批准号:
10730575 - 财政年份:2023
- 资助金额:
$ 45.3万 - 项目类别:
相似海外基金
Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
- 批准号:
EP/Y000331/1 - 财政年份:2023
- 资助金额:
$ 45.3万 - 项目类别:
Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
- 批准号:
10677295 - 财政年份:2023
- 资助金额:
$ 45.3万 - 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
- 批准号:
10635599 - 财政年份:2023
- 资助金额:
$ 45.3万 - 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
- 批准号:
10752320 - 财政年份:2023
- 资助金额:
$ 45.3万 - 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
- 批准号:
478927 - 财政年份:2023
- 资助金额:
$ 45.3万 - 项目类别:
Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
- 批准号:
10855703 - 财政年份:2023
- 资助金额:
$ 45.3万 - 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
- 批准号:
10654210 - 财政年份:2023
- 资助金额:
$ 45.3万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 45.3万 - 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
- 批准号:
10667952 - 财政年份:2023
- 资助金额:
$ 45.3万 - 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
- 批准号:
10726986 - 财政年份:2023
- 资助金额:
$ 45.3万 - 项目类别:














{{item.name}}会员




